Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
278,343,151
-
Shares change
-
+106,509,891
-
Total reported value, excl. options
-
$467,625,172
-
Value change
-
+$175,856,984
-
Put/Call ratio
-
46%
-
Number of buys
-
71
-
Number of sells
-
-36
-
Price
-
$1.68
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2024
145 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2024.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 278,343,151 shares
of 363,214,619 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include Artal Group S.A. (175,099,384 shares), FMR LLC (38,687,123 shares), BlackRock Inc. (9,890,153 shares), BRAIDWELL LP (8,294,950 shares), VANGUARD GROUP INC (7,675,125 shares), ORBIMED ADVISORS LLC (5,846,100 shares), Point72 Asset Management, L.P. (4,121,191 shares), GEODE CAPITAL MANAGEMENT, LLC (3,250,535 shares), CITADEL ADVISORS LLC (2,409,456 shares), and NEA Management Company, LLC (2,382,286 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.